DOI: 10.12890/2026_007143
Intestinal pseudo-obstruction with life-threatening manifestations in a patient with adult-onset Still’s disease reactivation
Authors
siham.hachem@aphp.fr
Keywords
Adult-onset Still’s disease, acute intestinal pseudo-obstruction, cytokine storm, hemophagocytic lymphohistiocytosisAbstract
Introduction: Adult-onset Still’s disease (AOSD) is a rare systemic autoinflammatory disorder with heterogeneous clinical manifestations and potentially life-threatening complications. Gastrointestinal manifestations are rarely reported, with only a few cases of intestinal pseudo-obstruction described in the literature.
Case description: We report the case of a 35-year-old man with a history of AOSD in remission who developed acute non-bloody diarrhoea, progressive abdominal distension, and high-spiking fever. Imaging demonstrated small-bowel distension in the absence of mechanical obstruction. A thorough diagnostic workup ruled out infectious, metabolic, neoplastic, and autoimmune aetiologies, including Crohn’s disease and vasculitis. Endoscopic biopsies revealed interstitial colitis, and faecal calprotectin was elevated, consistent with intestinal inflammation. Laboratory findings showed marked systemic inflammation with hyperferritinaemia, reduced glycosylated ferritin fraction, and substantially elevated interleukin-18, supporting an AOSD disease flare. The final diagnosis was AOSD-associated intestinal pseudo-obstruction. Treatment with corticosteroids and anakinra led to rapid clinical improvement and rapid control of systemic inflammation.
Conclusion: This observation highlights that acute intestinal pseudo-obstruction may represent an uncommon but clinically significant manifestation of AOSD flare. Cytokine-driven gut dysmotility, particularly through IL-1 and IL-18 signalling, appears to be a plausible pathophysiological mechanism. Timely recognition and early introduction of targeted immunomodulatory therapy are critical to prevent severe complications.
References
- Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Sève P. Adult-onset Still’s disease. Autoimmun Rev. 2014;13(7):708-22. doi: 10.1016/j.autrev.2014.01.058.
- Rossignon P, Soupart A. Intestinal Pseudo-Obstruction with Life-Threatening Hypokalaemia in a Patient with Adult-Onset Still’s Disease. Eur J Case Rep Intern Med. 2023;10(6):003887. doi: 10.12890/2023_003887.
- Hori H, Yabe H, Fukuchi T, Sugawara H. A woman with adult-onset Still’s disease and acute intestinal pseudo-obstruction. Clin Case Rep. 2020;9(1):153-157. doi: 10.1002/ccr3.3488.
- Li K, Pan X, Guo H, Jiang S, Fang X. Fatal Acute Intestinal Obstruction with Hemophagocytic Lymphohistiocytosis and Multiple Organ Failure in Adult-Onset Still’s Disease: A Rare Case Report. J Inflamm Res. 2025;18:5161-5171. doi: 10.2147/JIR.S509898.
- Manzotti C, Castellani M, Murgo A, Basilisco G. Duodenojejunal inflammation causing chronic vomiting in adult-onset Still’s disease. BMJ Case Rep. 2023;16(2):e252345. doi: 10.1136/bcr-2022-252345.
- Lee YH, Song GG. Associations between circulating interleukin-18 levels and adult-onset Still’s disease: a meta-analysis. J Rheum Dis. 2025;32(1):48-56. doi: 10.4078/jrd.2024.0095
- Girard C, Rech J, Brown M, Allali D, Roux-Lombard P, Spertini F, et al. Elevated serum levels of free interleukin-18 in adult-onset Still’s disease. Rheumatology (Oxford). 2016;55(12):2237-2247. doi: 10.1093/rheumatology/kew300.
- Narayanan A, Kim C, Dennett ER. Atypical case of Crohn’s colitis in a patient with adult-onset Still’s disease. BMJ Case Rep. 2021;14(6):e232593. doi: 10.1136/bcr-2019-232593.
- Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003;49(5):633-9. doi: 10.1002/art.11368.
- Ohama T, Hori M, Momotani E, Iwakura Y, Guo F, Kishi H, et al. Intestinal inflammation downregulates smooth muscle CPI-17 through induction of TNF-alpha and causes motility disorders. Am J Physiol Gastrointest Liver Physiol. 2007;292(5):G1429-38. doi: 10.1152/ajpgi.00315.2006.
- Kanai T, Watanabe M, Okazawa A, Nakamaru K, Okamoto M, Naganuma M, et al. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn’s disease. Gastroenterology. 2000;119(6):1514-23. doi: 10.1053/gast.2000.20260.